Curis, Inc.

519 articles about Curis, Inc.

• Curis, Inc. Announces Initiation of Expansion Cohort in Collaborator Genentech, Inc.'s Phase I Clinical Trial of a Systemically Administered Hedgehog Antagonist

  10/16/2007

• Curis, Inc. to Present at Biotechnology Industry Organization (BIO) InvestorForum 2007

  10/3/2007

• Curis, Inc. Provides Program Update on Development Candidate CUDC-101 and Its Targeted Cancer Drug Development Platform

  9/25/2007

• Curis, Inc. to Present at the Wall Street Analyst Forum's 18th Annual Analyst Conference

  9/13/2007

• Curis, Inc. Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications

  8/28/2007

• Curis, Inc. to Present at the Noble Financial Small Cap Equity Conference

  8/16/2007

• Curis, Inc. Announces Agreement for $13 Million Private Placement

  8/6/2007

• Curis, Inc. Reports Second Quarter 2007 Financial Results

  7/31/2007

• Curis, Inc. to Release Second Quarter 2007 Financial Results and Hold Conference Call on July 31, 2007

  7/24/2007

• Curis, Inc. Says Ortho Biotech Products, L.P. Plans to End License Agreement

  5/21/2007

• Curis, Inc. Presentation Time at Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference Changes to 8:40 a.m.

  5/11/2007

• Curis, Inc. to Present at Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference

  5/10/2007

• Curis, Inc. Provides Update on Hedgehog Agonist Hair Growth Program

  5/9/2007

• Curis, Inc. Reports First Quarter 2007 Financial Results

  5/2/2007

• Curis, Inc. to Release First Quarter 2007 Financial Results and Hold Conference Call on May 2, 2007

  4/25/2007

• Curis, Inc. Announces Hedgehog and Wnt Antagonist Data Presentation at American Association for Cancer Research

  4/17/2007

• Curis, Inc. to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference

  4/11/2007

• The Day In Review: Critical Therapeutics, Inc. Climbs On Co-Promotion Deal

  3/14/2007

• Curis, Inc. Selects First Development Candidate from its Targeted Cancer Drug Development Platform

  3/14/2007

• Curis, Inc. Reports Fourth Quarter And Year-End 2006 Financial Results

  2/14/2007